Molecules Engineered Against Oncogenic Proteins and Cancer pre SCIENCE & POP SCIENCE CEO and Portfolio Manager

CEO and Portfolio Manager

gaining over 25 million views

the Ascendancy dispatches one of its brightest young military officers to root out the unseen assailants

sardines-and how these games relate to the nature of God

Deemed over-privileged for her beauty

Molecules Engineered Against Oncogenic Proteins and Cancer pre SCIENCE & POP SCIENCE CEO and Portfolio ManagerA comprehensive review of the latest molecular advances in cancer treatment Featuring 91 total small molecule kinase KRAS inhibitors, 80 of which are FDA approved, Molecules Engineered Against Oncogenic Proteins and Cancer documents the recent scientific advances that have transformed one of medicines most challenging areascancer treatment. Most of these inhibitors specifically block oncogene induced carcinogenic proteins with results that have